Biomerica (BMRA) Share-based Compensation Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | -46.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -46.74% |
| Nov 30, 2025 | -39.05% |
| Aug 31, 2025 | -24.09% |
| May 31, 2025 | -28.91% |
| Feb 28, 2025 | -34.60% |
| Nov 30, 2024 | 85.64% |
| Aug 31, 2024 | -37.78% |
| May 31, 2024 | -15.01% |
| Feb 29, 2024 | -13.33% |
| Nov 30, 2023 | -37.36% |
| Aug 31, 2023 | 254.75% |
| May 31, 2023 | -19.70% |
| Feb 28, 2023 | 34.47% |
| Nov 30, 2022 | 121.84% |
| Aug 31, 2022 | 273.17% |
| May 31, 2022 | 299.64% |
| Feb 28, 2022 | 33.29% |
| Nov 30, 2021 | 185.42% |
| Aug 31, 2021 | 240.67% |
| May 31, 2021 | 253.13% |
| Feb 28, 2021 | 335.94% |
| Nov 30, 2020 | 1,172.29% |
| Aug 31, 2020 | -4.58% |
| May 31, 2020 | 208.98% |
| Feb 29, 2020 | 162.10% |
| Nov 30, 2019 | 201.29% |
| Aug 31, 2019 | 224.00% |
| May 31, 2019 | 34.62% |
| Feb 28, 2019 | 80.64% |
| Nov 30, 2018 | -22.86% |
| Aug 31, 2018 | 202.52% |
| May 31, 2018 | 24.05% |
| Feb 28, 2018 | 13.96% |
| Nov 30, 2017 | -32.71% |
| Aug 31, 2017 | 62.95% |
| Feb 28, 2017 | -4.66% |
| Aug 31, 2016 | -41.99% |
| May 31, 2016 | -69.72% |
| May 31, 2015 | -44.92% |
| Feb 28, 2015 | -39.17% |
| Feb 28, 2014 | 11.68% |